icon-    folder.gif   Conference Reports for NATAP  
 
  (APASL) 24th Conference of the Asian Pacific
Association for the Study of the Liver
12-15 March, 2014
Brisbane, Australia
Back grey_arrow_rt.gif
 
 
 
Once Daily Sofosbuvir/Ledipasvir Fixed-Dose Combination With or Without Ribavirin: Data From the ELECTRON Trials
 
 
  Reported by Jules Levin
Asian Pacific Association for the Study of the Liver (APASL), March 1215, 2014, Brisbane, Australia
 
Edward J. Gane,1 Robert H. Hyland,2 Xiao Ding,2 Evguenia S. Svarovskaia,2 Phillip S. Pang,2
William T. Symonds,2 John G. McHutchison,2 Catherine A. Stedman3 1Auckland Clinical Studies, Auckland, New Zealand; 2Gilead Sciences, Inc., Foster City, CA, USA; 3Christchurch Clinical Studies Trust, Christchurch, New Zealand

APASL1.gif

APASL2.gif

APASL3.gif

APASL4.gif

APASL5.gif

APASL6.gif

APASL7.gif

APASL8.gif

APASL9.gif